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Although Equine Infectious Anemia (EIA) is endemic in the
northern area of Argentina, its epidemiological situation varies
along the extent of the country, with a low prevalence in the
central region and free-status in Patagonia (southern region).
Argentinian legislation imposes the immediate euthanasia of
horses detected as positive by agar gel immunodiffusion test
(AGID). This report describes the consequences of EIA virus
infection in a farm dedicated to the production of crossbreeding
horses (Criollo, Arabian and Quarter horse) located in Baradero,
150 km northwest of Buenos Aires. This horse population (n: 124)
had not been tested for EIA in the last 3 years, and there was no
EIA control on animals admitted into the farm. The observation
that motivates the EIA screening was the death, with no attrib-
utable causes, of 10 horses during last year. On March 21st 2015,
the adult population of horses was tested for EIA by AGID.
Twenty-four out of 109 (22%) horses were found positive. The
Animal Health Authorities (SENASA) were notiﬁed and these
animals were immediately euthanized, and the farm quarantined.
After this, three additional AGID tests were conducted on adult
horses, and other three on the whole population (including foals
at foot). The obtained results are shown in the following table.March 21st May 15th June 23rd July 30th August 28th September 17th October 5th
Horses tested Adults Adults and foals at foot
109 83 67 68 83 82 82
AGID Positives 24 20 5 3 1 0 0
Prevalence 22% 24% 7% 4% 1% 0% 0%As result of EIA infection, 53 horses in all (43% of total population)
had to be euthanized. The 29 horses which tested positive during
the six-month period of additional testing either contracted the
infection during this period or had been already infected when
introduced into the farm. The inappropriate handling, with horses
being either ignored in one of the tests or introduced into the
farm during quarantine (shown by the incongruity in the number
of horses tested in each occasion), could be the reason for the long
time taken to control the infection. Even though all horses
resulted negative in the last two tests, the farm still remains
quarantined; another control 60 days after, with negative results,
is required. The present work illustrates the devastating conse-
quences of EIA infection, as it has brought along important eco-
nomic losses for the owner, due both to the loss of positive EIA
horses, which have been euthanized, as to the restrictions for the
movement and sales of horses from this breeding farm. Moreover,
this report emphasizes the importance of promoting EIA sur-
veillance in the area considered as “low prevalence”, considering
this area is where the most valuable horses are bred in Argentina.
It is also necessary to raise awareness that it is mandatory to
strictly comply with legislation when dealing with EIA infection,
which implies control of all horses (even foals on foot) in the
facility at the same time and prohibition of entry/exit of new in-
dividuals if untested.132
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Equine arteritis virus (EAV) is the causative agent of equine viral
arteritis (EVA), a respiratory and reproductive disease of equids.
Affected adult horses make a complete recovery, but a percentage
of infected stallions may become long-term carriers. The genome
of EAV has a length of 12.7kb and contains seven open reading
frames (ORFs). ORFs 1a and 1b represent seventy-ﬁve percent of
the viral genome and code for replicase and polymerase activities.
ORFs 2-7 are nested and code for the structural proteins of the
virus. EAV is widely distributed in equine populations around the
world and although there is only one serotype for EAV, consider-
able variation exists between ﬁeld strains. At present, the serum
neutralisation test (SNT) is the principal serological assay used to
detect EAV, but the SNT is expensive and time consuming to
perform. Additionally, several laboratories have reported prob-
lems relating to serum cytotoxicity in lower serum dilutions. To
overcome these limitations, considerable efforts have been un-
dertaken to develop an ELISA, but with limited success so far. The
antibody response of an individual horse differs depends on its
host MHC (ELA) genotype, the EAV strain, and the duration/type of
infection. A peptide microarray was developed using the
commercially available PEPperCHIP® microarray platform to
identify immunodominant B cell (antibody) epitopes of EAV. The
whole EAV strain Bucyrus amino acid sequence was transformed
into a total of 625 peptide overlapping peptides that were syn-thesized and spotted in duplicate onto a microarray slide. A panel
of 28 ﬁeld samples representing a selection of sera generated
against a variety of known EAV genotypes was tested using the
microarray. Of the 625 peptides, 97 peptides (15.52%) showed
reactivity with the EAV positive samples. No single peptide was
detected by all the positive serum samples. Seven peptides
repeatedly showed reactivity above the cut-off and were consid-
ered to have diagnostic potential. Five of these peptides were
within the immunodominant GP5 protein and two within the
replicase polyprotein region NSP2 and NSP10 located in ORF1.
Based on the results obtained in this study, a peptide ELISA offers a
promising approach as an alternative to the SNT for the detection
of antibodies to EAV. Further development and optimization is
required to determine if the peptide candidates identiﬁed through
this study offer the sensitivity and speciﬁcity required for the
diagnosis of EAV.
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